Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Practical management of adverse events related to apomorphine therapy

Bhidayasiri R, Garcia Ruiz PJ, Henriksen T.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S42-S48. doi: 10.1016/j.parkreldis.2016.11.017. Epub 2016 Nov 27.

The role of dopamine in the pathophysiology and treatment of apathy

Chong TT, Husain M.

Prog Brain Res. 2016;229:389-426. doi: 10.1016/bs.pbr.2016.05.007. Epub 2016 Jul 29.

LRRK2 at the interface of autophagosomes, endosomes and lysosomes

Roosen DA, Cookson MR.

Mol Neurodegener. 2016 Dec 7;11(1):73. doi: 10.1186/s13024-016-0140-1.

Gastrostomy with peritoneal collar versus percutaneous endoscopic gastrostomy

Tudor C, Branescu C, Savlovschi C, El-Khatib A, Pantu H, Nica A, Dascalu AM, Masoumeh B, Tudor AS, Oprescu SM, Serban D.

J Med Life. 2016 Oct-Dec;9(4):408-412.

Interleaving subthalamic nucleus deep brain stimulation to avoid side effects while achieving satisfactory motor benefits in Parkinson disease: A report of 12 cases

Zhang S, Zhou P, Jiang S, Wang W, Li P.

Medicine (Baltimore). 2016 Dec;95(49):e5575. doi: 10.1097/MD.0000000000005575.

Jejunitis secondary to Duodopa® probe, a different complication

Magaz Martínez M, Martínez Porras JL, Oliva B, Abreu L.

Rev Esp Enferm Dig. 2016 Dec;108(12):815-816.

Unmet needs in Parkinson's disease: New horizons in a changing landscape

Chaudhuri KR, Bhidayasiri R, van Laar T.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S2-S8. doi: 10.1016/j.parkreldis.2016.11.018. Epub 2016 Dec 6.

Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease

Gambardella S, Biagioni F, Ferese R, Busceti CL, Frati A, Novelli G, Ruggieri S, Fornai F.

Front Neurosci. 2016 Nov 24;10:532. doi: 10.3389/fnins.2016.00532. eCollection 2016.

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

Di Giovanni G, Svob Strac D, Sole M, Unzeta M, Tipton KF, Mück-Šeler D, Bolea I, Della Corte L, Nikolac Perkovic M, Pivac N, Smolders IJ, Stasiak A, Fogel WA, De Deurwaerdère P.

Front Neurosci. 2016 Nov 24;10:541. doi: 10.3389/fnins.2016.00541. eCollection 2016.

Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy

Bhidayasiri R, Boonpang K, Jitkritsadakul O, Calne SM, Henriksen T, Trump S, Chaiwong S, Susang P, Boonrod N, Sringean J, van Laar T, Drent M, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S49-S55. doi: 10.1016/j.parkreldis.2016.11.014. Epub 2016 Dec 9.

The efficacy of apomorphine - A non-motor perspective

Rosa-Grilo M, Qamar MA, Evans A, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S28-S35. doi: 10.1016/j.parkreldis.2016.11.020. Epub 2016 Dec 9.

Aquaporins in the Spinal Cord

Oklinski MK, Skowronski MT, Skowronska A, Rützler M, Nørgaard K, Nieland JD, Kwon TH, Nielsen S.

Int J Mol Sci. 2016 Dec 7;17(12):2050. doi: 10.3390/ijms17122050.

Accelerometer based analysis of gait initiation failure in advanced juvenile parkinsonism: a single subject study

Ishii M, Mashimo H.

J Phys Ther Sci. 2016 Nov;28(11):3252-3256. doi: 10.1589/jpts.8.3252. Epub 2016 Nov 29.

A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification

Shi CH, Zhang SY, Yang ZH, Yang J, Shang DD, Mao CY, Liu H, Hou HM, Shi MM, Wu J, Xu YM.

Mov Disord. 2016 Dec;31(12):1905-1909. doi: 10.1002/mds.26828.

Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale

Goetz CG, Liu Y, Stebbins GT, Wang L, Tilley BC, Teresi JA, Merkitch D, Luo S.

Mov Disord. 2016 Dec;31(12):1865-1873. doi: 10.1002/mds.26847. Epub 2016 Nov 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias